PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-1.96%
Negative net income growth while AVGO stands at 22.20%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
0.40%
Some D&A expansion while AVGO is negative at -0.64%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-70.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-27.54%
Both cut yoy SBC, with AVGO at -10.06%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-630.56%
Negative yoy working capital usage while AVGO is 54.39%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-254.29%
AR is negative yoy while AVGO is 23.18%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
148.12%
Some inventory rise while AVGO is negative at -1180.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-117.81%
Both negative yoy AP, with AVGO at -152.79%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
40.91%
Lower 'other working capital' growth vs. AVGO's 299.52%. David Dodd would see fewer unexpected short-term demands on cash.
100.00%
Some yoy increase while AVGO is negative at -68.85%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-16.10%
Both yoy CFO lines are negative, with AVGO at -1.09%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-12.31%
Negative yoy CapEx while AVGO is 29.05%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
12.31%
Some acquisitions while AVGO is negative at -71.43%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-920.08%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-71.82%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-28.23%
We reduce yoy other investing while AVGO is 175.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-252.33%
Both yoy lines negative, with AVGO at -291.67%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
We repay more while AVGO is negative at -121.32%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
41.38%
We slightly raise equity while AVGO is negative at -49.45%. John Neff sees competitor possibly preserving share count or buying back shares.
98.30%
Repurchase growth above 1.5x AVGO's 12.33%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.